Merck Announces Out-Licensing Agreement for Investigational At...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
DARMSTADT, Germany, Nov. 9, 2020/PRNewswire-AsiaNet/-- Not intended for UK and US based media- Merck out-licenses Phase IIb-ready atacicept to Vera Therapeutics- Phase IIa trial conducted by Merck shows promising results in IgA nephropathy (IgAN), also known as "Berger's disease"- Out-...
Authors: LATEST ASIANET NEWS RELEASES